Royal Society of Chemistry, Reaction Chemistry and Engineering, 2(5), p. 308-319, 2020
DOI: 10.1039/c9re00395a
Full text: Unavailable
Formulating protein therapeutics into nanoparticles (NPs) of poly(lactic-co-glycolic acid) (PLGA) provides key features such as protection against clearance, sustained release and less side effects by possible attachment of targeting ligands.